Literature DB >> 20941945

Treatment of morphea or localized scleroderma: review of the literature.

Fernanda Aguiar Santos Vilela1, Sueli Carneiro, Marcia Ramos-e-Silva.   

Abstract

Scleroderma is a disease that affects the microvasculature and the connective tissue. These alterations produce fibrosis and blood vessel occlusion. Its cause is still unknown, although the exaggerated synthesis of collagens I and IV, detected in skin and vessels, may be related to genetic, immunologic and, less frequently, exogenous factors as inhalation of silica and polyvinyl chloride. There is a localized and a systemic form, which affects both adults and children. The treatment of the localized form, also called morphea, is still controversial, and, in this article, the authors will discuss the main agents that were found to improve the lesions and symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20941945

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  7 in total

1.  Late-onset en coup de sabre of the skull.

Authors:  Shaun V Mohan; Vinay Nittur; Kathryn J Stevens
Journal:  Skeletal Radiol       Date:  2013-04-25       Impact factor: 2.199

2.  Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.

Authors:  Suzanne C Li; Kathryn S Torok; Elena Pope; Fatma Dedeoglu; Sandy Hong; Heidi T Jacobe; C Egla Rabinovich; Ronald M Laxer; Gloria C Higgins; Polly J Ferguson; Andrew Lasky; Kevin Baszis; Mara Becker; Sarah Campillo; Victoria Cartwright; Michael Cidon; Christi J Inman; Rita Jerath; Kathleen M O'Neil; Sheetal Vora; Andrew Zeft; Carol A Wallace; Norman T Ilowite; Robert C Fuhlbrigge
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

Review 3.  Development of minimum standards of care for juvenile localized scleroderma.

Authors:  Tamás Constantin; Ivan Foeldvari; Clare E Pain; Annamária Pálinkás; Peter Höger; Monika Moll; Dana Nemkova; Lisa Weibel; Melinda Laczkovszki; Philip Clements; Kathryn S Torok
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

4.  Interventions for morphea.

Authors:  Julia V de Albuquerque; Brenda Ng Andriolo; Monica Ra Vasconcellos; Vinicius T Civile; Anne Lyddiatt; Virginia Fm Trevisani
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16

Review 5.  Localized scleroderma: clinical spectrum and therapeutic update.

Authors:  Mariana Figueiroa Careta; Ricardo Romiti
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

6.  Methotrexate: an effective monotherapy for refractory generalized morphea.

Authors:  Eftychia Platsidaki; Vassiliki Tzanetakou; Anargyros Kouris; Panagiotis G Stavropoulos
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-05-08

7.  Localized scleroderma associated with chronic hepatitis C.

Authors:  Felipe Ladeira de Oliveira; Luisa Kelmer Côrtes de Barros Silveira; Maria Lourdes Candela Rambaldi; Fabio Cuiabano Barbosa
Journal:  Case Rep Dermatol Med       Date:  2012-11-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.